Category Archives: Parkinson’s Treatment

October 15, 2020 06:45 ET | Source: Annovis Bio Inc. BERWYN, Pa., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Annovis Bio Inc Continue reading →

CHARLOTTE Parkinsons disease, (PD) which is a chronic and progressive movement disorder, affects 200,000 Americans annually. Treatments can help manage the chronic condition; however, there is no known cure. The disease can last for several years or become a lifelong challenge. Continue reading →

The president has had a life-threatening, infectious disease for over a week, and he and his doctors havent been very transparent about the timeline and course of his affliction. In lieu of detailed disclosures, reporters have to piece together his condition based on the treatments hes been receiving. Trump was started off on an experimental therapeutic an antibody cocktail and then advanced to another remdesivir Continue reading →

Health-care companies rose as investors rotated out of "growth" sectors like biotech stocks and into "value" sectors such as industrials. President Trump and his advisers have taken a more hands-on role than previously known in shaping Covid-19 recommendations from the Centers for Disease Control and Prevention, The Wall Street Journal reported. Shares of biotech Vertex Pharmaceuticals fell sharply after it halted a mid-stage trial of a treatment for a rare liver and lung disease, spurring worries that it would not be able to replicate success with a cystic-fibrosis treatment and diversify its revenue. Continue reading →

Stephanie Bowens | StarNews Correspondent When someone has dementia, or severe loss of memory and impairment in mental and behavioral abilities significant enough to interfere with daily function, it can dramatically impact the persons life and the lives of their loved ones. Dementia with Lewy Bodies, or DLB, is one of the most common causes of dementia and affects over a million people in the US. Dr Continue reading →

Earlier this year, health systems across the country suspended nearly all screening mammography due to COVID-19. Continue reading →

The latestrelease from Database of Data Bridge Market Research has recently published the Global research Report TitledParkinsons Disease Treatment Market. The study provides an overview of current statistics and future predictions of the Global Parkinsons Disease Treatment Market.The study highlights a detailed assessment of the Market and displays market sizing trends by revenue & volume (if applicable), current growth factors, expert opinions, facts, and industry-validated market development data. Global parkinsons disease market is anticipated to rise from its initial estimated value of USD 4.57 billion in 2018 to an estimated value of USD 7.57 billion by 2026, registering a CAGR of 6.5% in the forecast period of 2019-2026. Continue reading →

SAN DIEGO, Sept. 3, 2020 /PRNewswire/ --Neurocrine Biosciences, Inc. Continue reading →

TheGlobal Parkinsons Disease Treatment Market To Witness A Noteworthy Progression Over 2020-2026A fundamental outline of theParkinsons Disease Treatment Marketniche is presented by the Parkinsons Disease Treatment Market report that entails definitions, classifications, applications together with industry chain framework. TheParkinsons Disease Treatment Marketreport provides a far-reaching evaluation of necessary market dynamics and the latest trends Continue reading →

This article was originally published here NPJ Parkinsons Dis. 2020 Aug 20;6:18. doi: 10.1038/s41531-020-00123-0 Continue reading →